- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||fulranumab|
|Search PubMed titles||fulranumab|
|Search PubMed titles/abstracts||fulranumab|
|Fulranumab is an investigational, fully human IgG2κ monoclonal antibody targeting nerve growth factor (NGF).
Peptide sequence information for this antibody is available from its IMGT/mAb-DB record.
BLAST peptide sequence analysis reveals identical matches to peptide sequences submitted with patent US7601818 , which belong to antibody clone 4D4 therein.